Redmile Group’s Neuronetics STIM Stock Holding History

Redmile Group’s Portfolio STIM Stock Details STIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-394,355	Closed	-$6.32M	–	85
2021 Q2	$6.32M	Sell	394,355 -105,645	-21%	-$1.46M	0.09%	77
2021 Q1	$6.18M	Buy	+500,000	New	+$7.66M	0.09%	79
2018 Q4	–	Sell	-180,999	Closed	-$5.8M	–	89
2018 Q3	$5.8M	Sell	180,999 -119,001	-40%	-$3.62M	0.18%	63
2018 Q2	$7.98M	Buy	+300,000	New	+$8.16M	0.27%	54

Other funds holding STIM

Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KLC

Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Redmile Group's STIM Position: Q3 2021 in Review

Redmile Group sold out of Neuronetics (STIM) in Q3 2021, closing a stake of 394,355 shares — an estimated $6.32M sold.

Redmile Group first reported a position in STIM in Q2 2018 and held it in 4 quarters. The position peaked at $7.98M in Q2 2018. 97 funds tracked by Wall St. Rank hold STIM as of Q3 2021.

Redmile Group reported no remaining Neuronetics position as of Q3 2021 after selling out during the quarter.
Redmile Group sold 394,355 Neuronetics shares in Q3 2021, an estimated $6.32M.
Redmile Group first reported a position in Neuronetics in Q2 2018 and held it in 4 quarters.
Redmile Group's Neuronetics position peaked at $7.98M in Q2 2018.
97 funds tracked by Wall St. Rank held Neuronetics as of Q3 2021.

Based on Redmile Group's 13F filing for Q3 2021, filed 15 Nov 2021.